Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam Nanocrystal Injection for Pain After Abdominal Surgery
NCT06379165Phase 3Completed
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology
- Start
- May 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of meloxicam in postoperative pain, sponsored by CSPC ZhongQi Pharmaceutical Technology. Started May 2023; status: completed.
02
Drugs
meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06379165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06379165.